HyperAcute Lung: Phase I/II data

Data from the Phase I portion of a U.S. Phase I/II trial in 16 evaluable patients showed that HyperAcute Lung produced 6 cases of stable disease lasting for a median of 34.9 weeks. In the Phase II por...